Published
October 20, 2026
Canadian residents who were prescribed and took branded Yasmin or YAZ birth control pills and were later diagnosed with a blood clot, ischemic stroke, heart attack or gallbladder disease, along with their family members, can claim from a $9,050,000 CAD national settlement with Bayer by April 9, 2027. Payments are pro rata and capped by injury, and medical and pharmacy records are required.
Current Status
Claims are open, and the deadline is April 9, 2027 at 11:59 p.m. Eastern Time; mailed claims count if postmarked by then. The courts in Ontario, Québec and Saskatchewan have all approved the settlement, the last on March 19, 2026, and court-approved notices of settlement approval were published in October 2026. Payments are made after the claims deadline and the administrator’s review.Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Status
Claims Open
approved in Ontario, Québec and Saskatchewan · final approval complete
Claim Deadline
April 9, 2027
11:59 p.m. Eastern Time · online, email or mail
Estimated Payout
Up to $9,000 CAD
for a blood clot (VTE) · up to $13,500 CAD for a VTE death · pro rata by points
Proof Required
Yes — medical records
pharmacy or medical records of use · records of each diagnosis · government photo ID
What Changed Recently?
The national settlement, signed July 30, 2025, resolves three certified class actions: Schwoob v. Bayer Inc. in the Ontario Superior Court of Justice, Guindon v. Bayer Inc. in the Superior Court of Québec and Dembrowski v. Bayer Inc. in the Court of King’s Bench for Saskatchewan, along with 10 dormant proposed class actions in other provinces. The Québec court approved it on November 26, 2025, the Ontario court on November 27, 2025 and the Saskatchewan court on March 19, 2026. Court-approved notices of settlement approval dated October 8, 2026 opened the claims process, and class counsel announced it in a court-approved release on October 15, 2026.The lawsuits alleged that Yasmin and YAZ carried a higher risk of blood clots and gallbladder disease than other oral contraceptives, that the risk was known to the defendants, and that it was not communicated in a timely or adequate way. Bayer denies the allegations, makes no admission as to their truth and denies any wrongdoing. The allegations and this page are not medical advice.
Who Qualifies?
The user class is everyone resident in Canada who was prescribed and took branded Yasmin or YAZ and was later diagnosed with arterial thromboembolism, venous thromboembolism or gallbladder disease. The use must fall within these windows:• Start: December 10, 2004 for Yasmin, and January 6, 2009 for YAZ.
• End: November 30, 2011 for residents of Ontario and Québec, and October 4, 2016 for residents of the rest of Canada.
The settlement covers only Yasmin- and YAZ-branded pills distributed by Bayer in Canada, not generic versions. Family members with a derivative family-law claim through a user can also claim. People who opted out, parties to four listed individual lawsuits, and anyone who started a separate case against Bayer on the same subject are excluded.
How Much Can You Get?
The $9,050,000 CAD fund is all-inclusive. After $905,000 CAD for provincial health insurers and $6,000 CAD in representative-plaintiff honoraria, $8,139,000 CAD remains for class members, before administration costs and class counsel’s fees of 30% are deducted. Approved claims are paid pro rata by points, with a maximum for each injury:• Venous thromboembolism (pulmonary embolism or deep vein thrombosis): 100 points, up to $9,000 CAD
• Arterial thromboembolism (ischemic stroke or heart attack): 50 points, up to $4,500 CAD
• Gallbladder disease or removal diagnosed within six months of taking Yasmin or YAZ: 5 points, up to $500 CAD
• Death from venous thromboembolism: 150 points, up to $13,500 CAD
• Death from arterial thromboembolism: 125 points, up to $11,250 CAD
• Family members: 10% of the primary claim’s points, shared if more than one family member claims for the same user
The value of a point depends on the money left after deductions and the total points claimed, so the amounts above are caps, not guaranteed payments. According to the Ontario court’s reasons, claimants do not have to prove that Yasmin or YAZ caused their condition, only that they took it during the window and were later diagnosed with a qualifying condition. Payments are made by cheque. Money left over goes to Women’s Health Collective Canada.
What Proof or Notice ID Is Required?
No notice ID is mentioned in the settlement documents, but documentation is required. A user’s claim must include the signed claim form; proof of taking Yasmin or YAZ, such as a pharmacy printout, a letter from a physician or medical facility, or notes in medical records; medical records showing each qualifying diagnosis and its date; and a copy of valid government-issued photo ID. Family members need proof of the relationship, and estates and representatives need proof of their authority. The notice says medical records can take time to retrieve.The claims administrator’s decisions are final. Reconsideration is available only when a claim is fully disallowed for fraud or found ineligible, and must be requested within 21 days.
What Is the Deadline?
Claims must be received by April 9, 2027 at 11:59 p.m. Eastern Time, or postmarked by then if mailed. The settlement documents allow claims online, by email or by mail, in English or French.How Do You Take Action?
The claim form is available on the official settlement website, run by the claims administrator, Epiq Class Action Services Canada Inc.What Happens Next?
Under the distribution protocol, the administrator sends a confirmation or deficiency letter within 90 days of receiving a claim, claimants have 45 days to fix a deficiency, determinations follow a 90-day review period after the deadline and cure period, and payments are made within 30 days after the fund is allocated.Sources and Verification
• Long-form and short-form notices of settlement approval (October 8, 2026), the National Settlement Agreement (July 30, 2025) and the Benefits and Distribution Protocol• Ontario approval order and reasons, Schwoob v. Bayer Inc., 2025 ONSC 6607, No. CV-10-52030-00CP (November 27, 2025); Québec judgment, Guindon v. Bayer Inc., No. 500-06-000484-093 (November 26, 2025); Saskatchewan judgment, Dembrowski v. Bayer, 2026 SKKB 63, No. QBG-SA-01611-2009 (March 19, 2026)
• Court-approved release by class counsel (CNW, October 15, 2026)
Questions
Who can claim from the Yasmin and YAZ Canada settlement?
Canadian residents who were prescribed and took branded Yasmin or YAZ within the class period and were later diagnosed with a blood clot, ischemic stroke, heart attack or gallbladder disease, and family members with a derivative claim. Generic versions are not covered.
How much is the Yasmin and YAZ settlement payment?
Payments are pro rata by points with caps: up to $9,000 CAD for venous thromboembolism, $4,500 CAD for a stroke or heart attack, $500 CAD for gallbladder disease, $13,500 CAD for a death from venous thromboembolism and $11,250 CAD for a death from arterial thromboembolism. Family members receive 10% of the primary claim.
What records does a Yasmin or YAZ claim need?
A signed claim form, proof of taking Yasmin or YAZ such as pharmacy or medical records, medical records showing each qualifying diagnosis and its date, and a copy of government-issued photo ID.
What is the deadline for the Yasmin and YAZ settlement?
Claims must be received by April 9, 2027 at 11:59 p.m. Eastern Time, or postmarked by then if mailed.
Does Bayer admit Yasmin or YAZ caused injuries?
No. Bayer denies the allegations, makes no admission as to their truth and denies any wrongdoing.
For more class actions keep scrolling below.
Settlement Amount
$9,050,000 CAD
Case Title
Schwoob v. Bayer Inc. (Ontario); Guindon v. Bayer Inc. (Québec); Dembrowski v. Bayer Inc. (Saskatchewan)
Case Number
CV-10-52030-00CP; 500-06-000484-093; QBG-SA-01611-2009
Court
Ontario Superior Court of Justice, Superior Court of Québec and Court of King’s Bench for Saskatchewan
Final Approval Hearing
Approved November 26–27, 2025 and March 19, 2026
Québec, Ontario and Saskatchewan courts
Administrator
Epiq Class Action Services Canada Inc.
Official Website
Yasmin YAZ Class Action Canada
